Gene: ABHD12B
Official Full Name: abhydrolase domain containing 12Bprovided by HGNC
Gene Summary: Predicted to enable lysophospholipase activity and monoacylglycerol lipase activity. Predicted to be involved in monoacylglycerol catabolic process and phosphatidylserine catabolic process. Predicted to be active in endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24059 | ABHD12B Knockout cell line (HeLa) | Human | ABHD12B | 1:3~1:6 | Negative | Online Inquiry |
ABHD12B Gene Knockout Cell Lines are an advanced biological research tool designed to facilitate in-depth investigations into the biological functions and pathways associated with the ABHD12B gene. This gene is implicated in various cellular processes, including lipid metabolism and signal transduction pathways, which are vital for maintaining cellular homeostasis. By creating knockout cell lines, researchers can effectively silence the ABHD12B gene to study the consequent phenotypic effects, enabling a clearer understanding of its role in both normal physiology and disease states.
The primary function of these knockout cell lines is to provide a model for elucidating the molecular mechanisms underlying ABHD12B-related pathways. The targeted deletion of this gene permits the examination of metabolic alterations, variations in cellular signaling, and overall changes in cellular behavior in response to genetic modifications. This model is especially valuable for research into neurodegenerative diseases, where dysregulation of lipid metabolic pathways has been documented.
In a clinical context, the ABHD12B Gene Knockout Cell Lines hold promise for drug development and therapeutic strategies, particularly in understanding how genetic disruptions contribute to pathologies. Their use extends to identifying potential biomarkers for disease progression, thus paving the way for early diagnostic methods or novel treatment interventions.
What sets this product apart from alternative options is its precision and reliability. Our knockout cell lines are engineered using state-of-the-art CRISPR technology, ensuring high specificity in gene editing, which results in reproducible and consistent experimental outcomes. Furthermore, this product is complemented by detailed characterization data, which provides users with essential insights for experimental design and application.
Researchers and clinicians will find exceptional value in the ABHD12B Gene Knockout Cell Lines due to their versatility and ability to accelerate the understanding of complex biological systems. By leveraging this innovative product, users can gain deeper insights into the molecular underpinnings of various diseases, ultimately aiding in the quest for effective therapies.
As a leader in the field of genetic tools, our company is committed to delivering high-quality research products supported by robust scientific expertise, ensuring that you have the best resources at your disposal to advance your research objectives.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.